Songran Liu

机构：Sun Yat-sen University, Chinese University of Hong Kong, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, University of Hong Kong · ORCID：0000-0001-8770-7962

发表论文 44 篇 · 总被引 639 次 · h-index 13

代表论文

• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 73)
• A lncRNA signature associated with tumor immune heterogeneity predicts distant metastasis in locoregionally advanced nasopharyngeal carcinoma (2022 · Nature Communications · 被引 70)
• Assessing dynamic metabolic heterogeneity in non-small cell lung cancer patients via ultra-high sensitivity total-body [18F]FDG PET/CT imaging: quantitative analysis of [18F]FDG uptake in primary tumors and metastatic lymph nodes (2022 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 41)
• DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway (2022 · EBioMedicine · 被引 39)
• Patlak-Ki derived from ultra-high sensitivity dynamic total body [18F]FDG PET/CT correlates with the response to induction immuno-chemotherapy in locally advanced non-small cell lung cancer patients (2023 · European Journal of Nuclear Medicine and Molecular Imaging · 被引 23)
• Lymphovascular invasion represents a superior prognostic and predictive pathological factor of the duration of adjuvant chemotherapy for stage III colon cancer patients (2023 · BMC Cancer · 被引 21)